mazindol has been researched along with Injuries, Spinal Cord in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Excerpt | Relevance | Reference |
---|---|---|
"Pretreatment with mazindol prevented the decrease in MAP and the increase in plasma renin activity (PRA) following 2DG infusions without modifying increased thirst, water intake, or AVP responses to glucoprivation." | 1.26 | Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans. ( Campbell, RG; Lilavivat, U; Robertson, GL; Thompson, DA; Welle, SL, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thompson, DA | 1 |
Campbell, RG | 1 |
Lilavivat, U | 1 |
Welle, SL | 1 |
Robertson, GL | 1 |
1 other study available for mazindol and Injuries, Spinal Cord
Article | Year |
---|---|
Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans.
Topics: Arginine Vasopressin; Central Nervous System; Deoxy Sugars; Deoxyglucose; Glucose; Humans; Male; Maz | 1981 |